LONDON (Reuters) - The first people vaccinated with an experimental Ebola shot being developed by U.S. drugmaker Merck and Canada's NewLink have had no serious side effects so far but a few experienced mild fever, researchers said on Tuesday. The shot, one of several being rushed through human testing in the hope they can be approved for use in the Ebola epidemic currently raging in West Africa, is going through initial human safety tests at the University Hospitals of Geneva. "After his or her injection, each volunteer was kept under observation for 1. ... via Health News Headlines - Yahoo News Read More Here..
Lake forest health and fitness http://ift.tt/1yGu8lE
No comments:
Post a Comment